Interleukin-10 produced by the innate immune system masks in vitro evidence of acquired T-cell immunity to E. coli

Scandinavian Journal of Immunology

Volumn 52, Issue 1, 2000, Pages 13-20

  Hessle, C ^a   Hanson, L A ^b   Wold, A E ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; GAMMA INTERFERON; HLA D ANTIGEN; IMMUNOGLOBULIN G1; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; TUBERCULIN;

ANTIGEN EXPRESSION; ARTICLE; BACTERIAL IMMUNITY; CANDIDA ALBICANS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MEMORY CELL; MONONUCLEAR CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD1; ESCHERICHIA COLI; HUMANS; IMMUNITY; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0033919802     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00741.x     Document Type: Article

References (39)

1. 1 Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84: 4008-27.
2. 2 Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
3. 3 Vosti KL, Goldberg LM, Monto AS, et al. Host parasite interaction in patients with infections due to Escherichia coli. 1. The serogrouping of E. coli from intestinal and extraintestinal sourses. J Clin Invest 1964;43:2377-85.
4. 4 Sears HJ, Brownlee I. Further observations on the persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol 1951;63:47-57.
5. 5 Tullus K, Kuhn I, Orskov I, et al. The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol Infect 1992;108:415-21.
6. 6 Wold AE, Caugant DA, Lidin-Janson G, et al. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 1992;165:46-52.
7. 7 Adlerberth I, Jalil F, Carlsson B, et al. High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect 1998;121:587-98.
8. 8 Moreau MC, Ducluzeau R, Guy-Grand D, et al. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect Immun 1978;21:532-9.
9. 9 Wold AE, Dahlgren UI, Hanson LA, et al. Difference between bacterial and food antigens in mucosal immunogenicity. Infect Immun 1989;57:2666-73.
10. 10 Lodinova-Zadnikova R, Slavikova M, Tlaskalova-Hogenova H, et al. The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Pediatr Res 1991;29:396-9.
11. 11 Winberg J. Studies of urinary tract infections in infancy and childhood. I. Antibody response in different types of urinary tract infections caused by coliform bacteria. Br Med J 1983;524-7.
12. 12 Mannhalter JW, Zlabinger GJ, Ahmad R, et al. Human T cell proliferation in response to E. coli presented by autologous macrophages is antigen specific. Clin Exp Immunol 1983;54:95-102.
13. 13 Eibl M, Mannhalter JW, Ahmad R. Macrophage - lymphocyte interaction in response to a bacterial antigen (E. coli). Clin Exp Immunol 1982;47:260-8.
14. 14 Duchmann R, Marker-Hermann E, Meyer zum Buschenfelde KH. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol 1996;44:71-9.
15. 15 Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-55.
16. 16 Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999;116:276-82.
17. 17 Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000;00:000-000. (In press).
18. 18 de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-20.
19. 19 Galanos C, Luderitz O, Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem 1969;9:245-9.
20. 20 Mattsby Baltzer I, Lindgren K, Lindholm B, et al. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect Immun 1991;59:689-95.
21. 21 Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-81.
22. 22 Telemo E, Karlsson M, Dahlman-Hoglund A, et al. Oral tolerance in experimental animals. Int Arch Allergy Immunol 1997;113:219-23.
23. 23 Husby S, Mestecky J, Moldoveanu Z, et al. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663-70.
24. 24 Thomas HC, Parrott MV. The induction of tolerance to a soluble protein antigen by oral administration. Immunology 1974;27:631-9.
25. 25 Challacombe SJ, Tomasi TB Jr. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 1980;152:1459-72.
26. 26 Chen Y, Kuchroo VK, Inobe J, et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
27. 27 Orskov F, Orskov I. From the National Institutes of Health. J Infect Dis 1983;148:346-57.
28. 28 Wennerås C, Quadri F, Bardhan PK, et al. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun 1999;67:6234-41.
29. 29 Wennerås C, Svennerholm AM, Czerkinsky C. Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun 1994;62:874-9.
30. 30 Hofstra H, Dankert J. Major outer membrane proteins: common antigens in Enterobacteriaceae species. J Gen Microbiol 1980;119:123-31.
31. 31 Henriksen AZ, Maeland JA. Immunoadsorbent-purified antibodies in the study of antigenic relatedness of outer membrane proteins of enteric bacilli. Acta Pathol Microbiol Immunol Scand [B] 1986;94: 257-63.
32. 32 Kersten CM, McCluskey RT, Shaw WH, et al. Responses of human T cells to dominant discrete protein antigens of Escherichia coli and Pseudomonas aeruginosa. Scand J Immunol 1994;40:151-7.
33. 33 Schlaak JF, Nieder P, Meyer zum Buschenfelde KH, et al. Human T helper cells reactive with somatic bacterial antigens belong to the Th1 subset. Med Microbiol Immunol Berl 1994;183:169-75.
34. 34 Hauer AC, Breese EJ, Walker-Smith JA, et al. The frequency of cells secreting interferon-gamma and interleukin-4, -5, and -10 in the blood and duodenal mucosa of children with cow's milk hyper-sensitivity. Pediatr Res 1997;42:629-38.
35. 35 Crabbe PA, Bazin H, Eyssen H, et al. The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. Int Arch Allergy 1968;34:362-75.
36. 36 Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993;177:397-407.
37. 37 Chouaib S, Welte K, Mertelsmann R, et al. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin-2 production and down-regulation of transferrin receptor expression. J Immunol 1985;135:1172-9.
38. 38 Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen [see comments]. Nat Med 1999;5:900-6.
39. 39 Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 1993;75:263-74.